UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Lowe's Companies
LOW
$104B
| $1.16B | 0.25% |
4,618,511
-1,297,552
| -22% | -$319M |
2013 Q2
49 quarters
|
|
77
Vertex Pharmaceuticals
VRTX
$129B
| $1.13B | 0.25% |
2,887,117
-180,356
| -6% | -$75.4M |
2013 Q2
49 quarters
|
|
|
SCHW
78
Charles Schwab
SCHW
$167B
| $1.11B | 0.24% |
11,592,153
-2,751,635
| -19% | -$261M |
2013 Q2
49 quarters
|
|
79
GE Vernova
GEV
$266B
| $1.11B | 0.24% |
1,798,799
-135,257
| -7% | -$81.9M |
2024 Q2
5 quarters
|
|
80
Boston Scientific
BSX
$61.1B
| $1.07B | 0.23% |
10,978,385
-1,771,685
| -14% | -$183M |
2013 Q2
49 quarters
|
|
81
KLA
KLAC
$257B
| $1.06B | 0.23% |
9,835,040
-1,718,370
| -15% | -$160M |
2013 Q2
49 quarters
|
|
82
Autodesk
ADSK
$49.1B
| $1.06B | 0.23% |
3,329,577
-620,636
| -16% | -$189M |
2013 Q2
49 quarters
|
|
83
T-Mobile US
TMUS
$164B
| $1.05B | 0.23% |
4,375,646
-689,757
| -14% | -$167M |
2013 Q2
49 quarters
|
|
84
Mercado Libre
MELI
$94.2B
| $1.04B | 0.23% |
446,939
-143,325
| -24% | -$344M |
2013 Q2
49 quarters
|
|
85
Alibaba
BABA
$274B
| $1.03B | 0.22% |
5,762,261
+772,642
| +15% | +$101M |
2014 Q3
44 quarters
|
|
86
Applovin
APP
$92.7B
| $1.02B | 0.22% |
1,416,259
-188,288
| -12% | -$86.8M |
2022 Q1
14 quarters
|
|
87
NextEra Energy
NEE
$161B
| $1B | 0.22% |
13,307,316
-2,738,208
| -17% | -$200M |
2013 Q2
49 quarters
|
|
88
Amphenol
APH
$214B
| $1,000M | 0.22% |
16,154,776
-2,598,356
| -14% | -$143M |
2013 Q2
49 quarters
|
|
89
Danaher
DHR
$154B
| $998M | 0.22% |
5,034,903
-1,329,760
| -21% | -$265M |
2013 Q2
49 quarters
|
|
90
Trane Technologies
TT
$106B
| $984M | 0.21% |
2,332,682
-424,568
| -15% | -$181M |
2013 Q2
49 quarters
|
|
91
Bristol-Myers Squibb
BMY
$121B
| $983M | 0.21% |
21,788,946
-3,420,584
| -14% | -$160M |
2013 Q2
49 quarters
|
|
92
Automatic Data Processing
ADP
$107B
| $981M | 0.21% |
3,342,645
-875,110
| -21% | -$263M |
2013 Q2
49 quarters
|
|
93
Eaton
ETN
$167B
| $973M | 0.21% |
2,600,098
-429,606
| -14% | -$156M |
2013 Q2
49 quarters
|
|
94
RTX Corp
RTX
$250B
| $968M | 0.21% |
5,786,411
-1,200,679
| -17% | -$186M |
2013 Q2
49 quarters
|
|
95
CrowdStrike
CRWD
$274B
| $965M | 0.21% |
7,870,468
-1,362,772
| -15% | -$155M |
2019 Q2
25 quarters
|
|
96
Ecolab
ECL
$78.9B
| $939M | 0.2% |
3,427,725
-597,300
| -15% | -$162M |
2013 Q2
49 quarters
|
|
97
Equinix
EQIX
$101B
| $929M | 0.2% |
1,186,497
+953,001
| +408% | +$745M |
2013 Q2
49 quarters
|
|
98
McKesson
MCK
$109B
| $919M | 0.2% |
1,188,957
-105,275
| -8% | -$74.1M |
2013 Q2
49 quarters
|
|
|
MRSH
99
Marsh
MRSH
$83.9B
| $916M | 0.2% |
4,543,833
-1,163,107
| -20% | -$239M |
2013 Q2
49 quarters
|
|
100
Synopsys
SNPS
$97.1B
| $912M | 0.2% |
1,848,456
-76,900
| -4% | -$43.5M |
2013 Q2
49 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.